CONDENSATE-TARGETED THERAPEUTIC METHODS FOR HUNTINGTON’S DISEASE: DISRUPTION OF mHTT PHASE-SEPARATED CONDENSATES TO RESTORE TRANSCRIPTION FACTOR AVAILABILITY AND GENE EXPRESSION; AND COMBINATION WITH MSH3 SOMATIC INSTABILITY INHIBITION
AU2026905785P0PendingOCEANSPARX PTY LTD
0 Cites 0 Cited by
Patent Information
- Application Number
- AU2026905785
- Authority / Receiving Office
- AU · AU
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2026-06-25
Need to check novelty before this filing date? Find Prior Art
No text content released.